Team develops DNA compounds that could help treat lupus

May 27, 2009

A research team led by a University of Iowa investigator has generated DNA-like compounds that effectively inhibit the cells responsible for systemic lupus erythematosus -- the most common and serious form of lupus. There currently is no cure for this chronic autoimmune condition that damages the skin, joints and internal organs and affects an estimated one million Americans.

The team, which included researchers at Boston University School of Medicine, demonstrated the anti-inflammatory effects of class R inhibitory oligonucleotides in laboratory experiments. The findings, which could eventually lead to new treatments, appear May 28 in BioMed Central's open access journal Arthritis Research and Therapy.

"The increased potency of class R inhibitory oligonucleotides for certain cells involved in lupus flare-ups could help patients by providing specific inhibition, yet allowing them to generate a protective immune response when needed," said the study's lead author, Petar Lenert, M.D., Ph.D., assistant professor of internal medicine at the University of Iowa Roy Carver College of Medicine.

During periodic flare-ups in people with lupus, the immune system overreacts and mistakenly attacks cells and tissues throughout the body, resulting in a range of symptoms including inflammation, pain and a characteristic "butterfly rash" across the cheeks.

Using human cell lines and isolated mouse cells, Lenert and his colleagues showed that the DNA-like compounds were able to selectively reduce the activity of two types of immune cells called autoreactive and dendritic . When given to mice with lupus, the compounds delayed death and reduced kidney damage, proving their effectiveness.

"With further testing, we hope that class R inhibitory oligonucleotides may become another weapon in the fight against lupus," Lenert said.

Lupus prevalence varies by country and ethnicity. It is much more common in women than men; nine out of 10 people with lupus are female. also is three times more common in African-American women than in Caucasian women and is more prevalent in women of Latino, Asian and Native American descent.

More information: DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas lpr/lpr mice in vivo, Petar Lenert, Kei Yasuda, Liliana Busconi, Patrice Nelson, Courtney Fleenor, Radhika S Ratnabalasuriar, Peter L Nagy, Robert F Ashman, Ian R Rifkin and Ann Marshak-Rothstein, Arthritis Research & Therapy, arthritis-research.com/

Source: University of Iowa (news : web)

Explore further: Firm targets 3D printing synthetic tissues, organs

add to favorites email to friend print save as pdf

Related Stories

DNA variations signal lupus risk

Jan 20, 2008

Scientists have pinpointed a set of common variations in human DNA that signal a higher risk for lupus in women who carry them. Some of these variations are more common in relatives of lupus patients, which may help future ...

Lupus gene finding prompts call for more DNA samples

Dec 02, 2007

Wellcome Trust researchers have identified a key gene involved in the disease Lupus, which affects around 50,000 people in the UK, mostly women. The lead researcher behind the study has called for more patients to volunteer ...

Rituximab reduces kidney inflammation in patients with lupus

Mar 04, 2009

Treatment with the targeted drug rituximab can significantly benefit some patients with severe lupus nephritis who do not respond to conventional therapy, according to a study appearing in an upcoming issue of the Clinical Jo ...

Cutting the brakes on the immune system

Aug 01, 2008

Your immune system may have more in common with a Corvette than you thought. When a virus or bacteria enters a human body, the immune system revs up to fight and expel the invader. Once the invader is gone, the body puts ...

Recommended for you

Firm targets 3D printing synthetic tissues, organs

48 minutes ago

(Medical Xpress)—A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term the company ...

Gate for bacterial toxins found

16 hours ago

Prof. Dr. Dr. Klaus Aktories and Dr. Panagiotis Papatheodorou from the Institute of Experimental and Clinical Pharmacology and Toxicology of the University of Freiburg have discovered the receptor responsible ...

User comments : 3

Adjust slider to filter visible comments by rank

Display comments: newest first

PPihkala
not rated yet May 27, 2009
I would be interested to know how vitamin D -status of lupus sufferers relates to their disease. Vitamin D is known to suppress inflammation and a bigger prevalence in darker skinned people also would support the theory that inadequate levels of vitamin D in blood could make lupus more active.
fixer
not rated yet May 28, 2009
Good question, unfortunately the team hasn't looked deep enough and are a little out of date.
Lupus is not a disease, it is a symptom of autoimmune disease.
The Marshall Protocol has now been released to the public after 7 years of testing and clinical studies.
Physorg missed it, It was reported by EurekAlert!
WHOOPS!
Nan2
not rated yet Jun 02, 2009
Lupus is but one of dozens of autoimmune diseases, not a symptom but a disease classified unto itself as others are, the criteria for each distinguished auto-immune disease is different in diagnosis, different body tissues or whole systems are affected by different autoimmune disorders. The demographic makeup of each of these disorders can also vary widely.

You may be confusing the classic 'butterfly rash' seen as a SYMPTOM with the disease. The disease called SLE (Systemic Lupus Erythmetatosis) The disease is quite serious and can attack kidney's, joint tissues, etc. During flares the rash is apparent. Not all suffers of SLE will always get the rash, therefore its highly doubtful vitamin D plays a significant role. There is a sub-set Lupus called Discoid lupus which is a less severe form of the disease and primarily affects the skin.

Vitamin D may play a role but certainly is not a curative or preventer in this and other serious auto-immune diseases. These are serious and very vexing diseases from which many people suffer. Like with other vexing and serious diseases and illnesses, the cause remains unknown except for a few which are totally hereditary. Great strides are being made in understanding these illnesses but there's no banana yet.

More news stories

Firm targets 3D printing synthetic tissues, organs

(Medical Xpress)—A University of Oxford spin-out, OxSyBio, will develop 3D printing techniques to produce tissue-like synthetic materials for wound healing and drug delivery. In the longer term the company ...

Survival hope for melanoma patients thanks to new vaccine

(Medical Xpress)—University of Adelaide researchers have discovered that a new trial vaccine offers the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability ...

Naps help infants learn

Sleep is essential in helping young children apply what they learn, according to new research by Rebecca Gómez, associate professor in the UA Department of Psychology. In this Q&A, she talks about her new ...

Robotics goes micro-scale

(Phys.org) —The development of light-driven 'micro-robots' that can autonomously investigate and manipulate the nano-scale environment in a microscope comes a step closer, thanks to new research from the ...

Biologists help solve fungi mysteries

(Phys.org) —A new genetic analysis revealing the previously unknown biodiversity and distribution of thousands of fungi in North America might also reveal a previously underappreciated contributor to climate ...